Anastasia Stefania Alexopoulos, MBBS

Assistant Professor of Medicine
Email address anastasia.alexopoulos@duke.edu

Originally from: Canada

Education and Training

  • Undergraduate: Imperial College London, UK
  • Medical School: Imperial College London, UK
  • Residency and Chief Residency: Internal Medicine, Emory University School of Medicine, Atlanta GA

Additional Training

  • Duke Clinical Research Training Program - MHS (2018-present)

Reasons I chose Duke:

  • Duke is a major academic center with cutting-edge research, but maintain a laid-back and relaxed vibe.
  • The program is uber supportive and expresses a genuine interest in the success of their fellows. For instance, as a research fellow you are encouraged and supported to pursue a Masters of Health Sciences degree through the Clinical Research Training Program.
  • The program is responsive to fellow feedback and wants to ensure the happiness of their fellows. This was abundantly clear during my interview day at Duke - the fellows seemed happy, and the program had clearly made changes in response to prior fellow feedback (e.g. no clinic/consult overlap while on Duke consults, changes to the paging system to avoid overburdening fellows, etc.).
  • The ability to practice in two hospital settings (Duke and the Durham VA), and they are right across the street from each other!
  • Affordable cost of living, such that fellows can be homeowners. I particularly loved the idea of having my own garden!

Happy surprises:

  • Duke is an exceedingly collaborative environment. You are very much encouraged to work with other Divisions, Departments, and even other hospitals, such as UNC. I’ve come to realize how important it is to be in a research environment that is flexible and open to collaboration.
  • Not really a surprise, but our group of fellows really love to spend time together outside of work. It is so great to be with friends/colleagues who enjoy their interests outside of work and are also extremely motivated to excel academically/clinically.

Honors, awards, achievements:

  • During my time at Duke I have received an award from the Endocrine Fellows Foundation, as well as a $40,000 award from the VA to conduct a pilot study as co-PI.
  • Since my time here, I have published three first-author reviews (including one in JAMA), two first-author research articles (with more on the way!), and have been involved in multiple other studies, including a systematic review and meta-analysis published in the Annals of Internal Medicine.
  • I have also attended and presented at Endocrine conferences, completed my Masters of Health Sciences (May 2020), and was recently elected into the AOA Medical Honor Society.

Plans after fellowship:
I am very grateful to be staying on as faculty at Duke! I will be working on expanding my research portfolio and submitting an early career award.

Education and Training

  • Fellowship, Endocrinology, Brigham and Women's Hospital, 2017 - 2018
  • Residency, Internal Medicine, Emory University School of Medicine, 2013 - 2016
  • M.B.B.S., Imperial College London (United Kingdom), 2012

Publications

Kobe, Elizabeth A., Clarissa J. Diamantidis, Hayden B. Bosworth, Clemontina A. Davenport, Megan Oakes, Anastasia-Stefania Alexopoulos, Jane Pendergast, Uptal D. Patel, and Matthew J. Crowley. “Racial Differences in the Effectiveness of a Multifactorial Telehealth Intervention to Slow Diabetic Kidney Disease.” Med Care 58, no. 11 (November 2020): 968–73. https://doi.org/10.1097/MLR.0000000000001387.

PMID
32833935
Full Text

Yang, Jeff Y., Andrew M. Moon, Hannah Kim, Virginia Pate, A Sidney Barritt, Matthew J. Crowley, John B. Buse, Til Stürmer, and Anastasia-Stefania Alexopoulos. “Newer second-line glucose-lowering drugs versus thiazolidinediones on cirrhosis risk among older US adult patients with type 2 diabetes.” J Diabetes Complications 34, no. 11 (November 2020): 107706. https://doi.org/10.1016/j.jdiacomp.2020.107706.

PMID
32843283
Full Text

Sagalla, Nicole, William S. Yancy, David Edelman, Amy S. Jeffreys, Cynthia J. Coffman, Corrine I. Voils, Anastasia-Stefania Alexopoulos, Matthew L. Maciejewski, Moahad Dar, and Matthew J. Crowley. “Factors associated with non-adherence to insulin and non-insulin medications in patients with poorly controlled diabetes.” Chronic Illn, October 25, 2020, 1742395320968627. https://doi.org/10.1177/1742395320968627.

PMID
33100020
Full Text

Crowley, Matthew J., Darren K. McGuire, Anastasia-Stefania Alexopoulos, Thomas Jon Jensen, Søren Rasmussen, Hans A. Saevereid, Subodh Verma, and John B. Buse. “Effects of Liraglutide on Cardiovascular Outcomes in Type 2 Diabetes Patients With and Without Baseline Metformin Use: Post Hoc Analyses of the LEADER Trial.” Diabetes Care 43, no. 9 (September 2020): e108–10. https://doi.org/10.2337/dc20-0437.

PMID
32647053
Full Text

Lunyera, Joseph, Dinushika Mohottige, Anastasia-Stefania Alexopoulos, Hilary Campbell, C Blake Cameron, Nicole Sagalla, Timothy J. Amrhein, et al. “Risk for Nephrogenic Systemic Fibrosis After Exposure to Newer Gadolinium Agents: A Systematic Review.” Ann Intern Med 173, no. 2 (July 21, 2020): 110–19. https://doi.org/10.7326/M20-0299.

PMID
32568573
Full Text

Li, Dandan, Jocelyn Anne Silvester, Matthew J. Crowley, Jeff Y. Yang, Anastasia-Stefania Alexopoulos, Yang Xu, Siyan Zhan, and Tiansheng Wang. “Assessing the association between dipeptidyl peptidase-4 inhibitors use and celiac disease through drug adverse event reporting.” Ther Adv Chronic Dis 11 (2020): 2040622320904301. https://doi.org/10.1177/2040622320904301.

PMID
32071711
Full Text

Wolf, Rachel A., J Sonya Haw, Sudeshna Paul, Melissa Spezia Faulkner, EunSeok Cha, M. K. Findley, Farah Khan, et al. “Hospital admissions for hyperglycemic emergencies in young adults at an inner-city hospital.” Diabetes Res Clin Pract 157 (November 2019): 107869. https://doi.org/10.1016/j.diabres.2019.107869.

PMID
31560962
Full Text

Alexopoulos, Anastasia-Stefania, William S. Yancy, David Edelman, Cynthia J. Coffman, Amy S. Jeffreys, Matthew L. Maciejewski, Corrine I. Voils, et al. “Clinical associations of an updated medication effect score for measuring diabetes treatment intensity.” Chronic Illn, October 25, 2019, 1742395319884096. https://doi.org/10.1177/1742395319884096.

PMID
31653175
Full Text

Alexopoulos, Anastasia-Stefania, and John B. Buse. “Initial injectable therapy in type 2 diabetes: Key considerations when choosing between glucagon-like peptide 1 receptor agonists and insulin.” Metabolism 98 (September 2019): 104–11. https://doi.org/10.1016/j.metabol.2019.06.012.

PMID
31255662
Full Text

Alexopoulos, Anastasia-Stefania, Rachel Blair, and Anne L. Peters. “Management of Preexisting Diabetes in Pregnancy: A Review.” Jama 321, no. 18 (May 14, 2019): 1811–19. https://doi.org/10.1001/jama.2019.4981.

PMID
31087027
Full Text

Pages